Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AGENUS INCAGEN · Entity 5774 | Director | February 05, 2024 | April 22, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AGENUS INC
Report date February 05, 2024 · Filed April 22, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $12.60 · Expires 2034-02-05 | Direct | 5,000 |
Reported balance
After 2024-02-05 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-02-05 · Grant · Acquired 5,000 · Balance 5,000 F1: The Stock Options were awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan on February 5, 2024 and will vest on February 5, 2025. The Stock Options were granted prior to the 1 for 20 reverse stock split, representing 100,000 Stock Options with an exercise price of $0.63. |
Filing footnotes · ownership attribution and instrument terms
F1: The Stock Options were awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan on February 5, 2024 and will vest on February 5, 2025. The Stock Options were granted prior to the 1 for 20 reverse stock split, representing 100,000 Stock Options with an exercise price of $0.63.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 05, 2024 Filed Apr 22, 2024 20:05 UTC | AGENUS INC AGEN · Entity 5774 | GrantStock Option · Derivative | 5,000 | $0.00 Strike: $12.60 | $0.00 |
DisclosureSEC source: 0000950170-24-046419 · ownership.xml · derivative · entry 1 Jeynes-Ellis Allison M · CIK 0001758521 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2034-02-05 F1 · derivative.exercise_date: The Stock Options were awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan on February 5, 2024 and will vest on February 5, 2025. The Stock Options were granted prior to the 1 for 20 reverse stock split, representing 100,000 Stock Options with an exercise price of $0.63. Read SEC document |
| January 08, 2023 Filed Jan 10, 2023 00:05 UTC | AGENUS INC AGEN · Entity 5774 | GrantStock Option · Derivative | 100,000 | $0.00 Strike: $2.40 | $0.00 |
DisclosureSEC source: 0000899243-23-001360 · doc4.xml · derivative · entry 1 Jeynes-Ellis Allison M · CIK 0001758521 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2033-01-08 F1 · derivative.exercise_date: Options of Common Stock were awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan (the "2019 Plan") on January 8, 2023. Options will vest on January 8, 2024. Read SEC document |
| February 04, 2022 Filed Feb 8, 2022 23:10 UTC | AGENUS INC AGEN · Entity 5774 | GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $2.39 | $0.00 |
DisclosureSEC source: 0000899243-22-005241 · doc4.xml · derivative · entry 1 Jeynes-Ellis Allison M · CIK 0001758521 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2032-02-04 F1 · derivative.exercise_date: Option awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan, as amended, and will vest on February 4, 2023. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 21:13 UTC | AGENUS INC AGEN · Entity 5774 | Exercise / conversionCommon Stock | 16,853 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-025024 · doc4.xml · nonDerivative · entry 1 Jeynes-Ellis Allison M · CIK 0001758521 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,176 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On June 16, 2020, Ms. Jeynes-Ellis was granted 16,853 Restricted Stock Units as part of her annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 16, 2021, this award vested in full and Ms. Jeynes-Ellis was issued the underlying 16,853 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan. F1 · price: On June 16, 2020, Ms. Jeynes-Ellis was granted 16,853 Restricted Stock Units as part of her annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 16, 2021, this award vested in full and Ms. Jeynes-Ellis was issued the underlying 16,853 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan. Read SEC document |
| June 15, 2021 Filed Jul 2, 2021 21:54 UTC | AGENUS INC AGEN · Entity 5774 | GrantStock Option · Derivative | 100,000 | $0.00 Strike: $3.18 | $0.00 |
DisclosureSEC source: 0000899243-21-027297 · doc4.xml · derivative · entry 1 Jeynes-Ellis Allison M · CIK 0001758521 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2030-12-17 F1 · derivative.exercise_date: Option was granted on January 1, 2021, subject to shareholder approval of an increase to the available pool under the Company's 2019 Equity Incentive Plan ("2019 Plan"), which was obtained at the Company's annual shareholder meeting on June 15, 2021. Option awarded in accordance with the 2019 Plan. Option vests in full on December 17, 2022. Read SEC document |
| December 17, 2020 Filed Dec 21, 2020 19:24 UTC | AGENUS INC AGEN · Entity 5774 | GrantStock Option (Right to buy) · Derivative | 100,000 | $0.00 Strike: $3.70 | $0.00 |
DisclosureSEC source: 0001745285-20-000049 · primary_doc.xml · derivative · entry 1 Jeynes-Ellis Allison M · CIK 0001758521 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2030-12-17 F1 · derivative.exercise_date: Stock Option awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan. The Stock Option vests in full on December 17, 2021 (provided Dr. Jeynes-Ellis continues to serve on the board on such date). Read SEC document |
| June 19, 2020 Filed Jun 23, 2020 20:41 UTC | AGENUS INC AGEN · Entity 5774 | Exercise / conversionRestricted Stock Unit · Derivative | 20,338 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001745285-20-000021 · primary_doc.xml · derivative · entry 2 Jeynes-Ellis Allison M · CIK 0001758521 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,338 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On June 19, 2019, Ms. Jeynes-Ellis was granted 20,338 Restricted Stock Units as part of her annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 19, 2020, this award vested in full and Ms. Jeynes-Ellis was issued the underlying 20,338 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan. F1 · price: On June 19, 2019, Ms. Jeynes-Ellis was granted 20,338 Restricted Stock Units as part of her annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 19, 2020, this award vested in full and Ms. Jeynes-Ellis was issued the underlying 20,338 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan. F1 · derivative.exercise_date: On June 19, 2019, Ms. Jeynes-Ellis was granted 20,338 Restricted Stock Units as part of her annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 19, 2020, this award vested in full and Ms. Jeynes-Ellis was issued the underlying 20,338 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan. F1 · derivative.expiration_date: On June 19, 2019, Ms. Jeynes-Ellis was granted 20,338 Restricted Stock Units as part of her annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 19, 2020, this award vested in full and Ms. Jeynes-Ellis was issued the underlying 20,338 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan. Read SEC document |
| June 19, 2020 Filed Jun 23, 2020 20:41 UTC | AGENUS INC AGEN · Entity 5774 | Exercise / conversionCommon Stock | 20,338 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001745285-20-000021 · primary_doc.xml · nonDerivative · entry 1 Jeynes-Ellis Allison M · CIK 0001758521 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,323 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On June 19, 2019, Ms. Jeynes-Ellis was granted 20,338 Restricted Stock Units as part of her annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 19, 2020, this award vested in full and Ms. Jeynes-Ellis was issued the underlying 20,338 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan. F1 · price: On June 19, 2019, Ms. Jeynes-Ellis was granted 20,338 Restricted Stock Units as part of her annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 19, 2020, this award vested in full and Ms. Jeynes-Ellis was issued the underlying 20,338 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan. Read SEC document |
| June 16, 2020 Filed Jun 17, 2020 20:57 UTC | AGENUS INC AGEN · Entity 5774 | GrantRestricted Stock Unit · Derivative | 16,853 | $0.00 | $0.00 |
DisclosureSEC source: 0001745285-20-000013 · primary_doc.xml · derivative · entry 1 Jeynes-Ellis Allison M · CIK 0001758521 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,191 Underlying: Common Stock · 16,853 shares Expires not disclosed F1 · derivative.exercise_price: Restricted Stock Unit was granted on June 16, 2020 in accordance with the Agenus Inc. 2019 Equity Incentive Plan. The award vests in full on June 16, 2021. F1 · derivative.expiration_date: Restricted Stock Unit was granted on June 16, 2020 in accordance with the Agenus Inc. 2019 Equity Incentive Plan. The award vests in full on June 16, 2021. F2 · balance_after: Includes 20,338 Restricted Stock Unit that are scheduled to vest on June 19, 2020. Read SEC document |
| December 24, 2019 Filed Dec 27, 2019 20:39 UTC | AGENUS INC AGEN · Entity 5774 | GrantStock Option (Right to buy) · Derivative | 75,000 | $0.00 Strike: $4.12 | $0.00 |
DisclosureSEC source: 0000899243-19-030107 · doc4.xml · derivative · entry 1 Jeynes-Ellis Allison M · CIK 0001758521 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2029-12-24 F1 · derivative.exercise_date: Option awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan and will vest on December 24, 2020. Read SEC document |
| June 19, 2019 Filed Jun 21, 2019 21:33 UTC | AGENUS INC AGEN · Entity 5774 | GrantRestricted Stock Unit · Derivative | 20,338 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-017841 · doc4.xml · derivative · entry 2 Jeynes-Ellis Allison M · CIK 0001758521 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,338 Underlying: Common Stock · 20,338 shares Expires not disclosed F2 · derivative.exercise_price: Restricted Stock Unit was granted on June 19, 2019, subject to shareholder approval of the Company's 2019 Equity Incentive Plan, which was obtained at the Company's annual shareholder meeting on June 19, 2019. Restricted Stock Unit awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan. The award vests on June 19, 2020. F2 · price: Restricted Stock Unit was granted on June 19, 2019, subject to shareholder approval of the Company's 2019 Equity Incentive Plan, which was obtained at the Company's annual shareholder meeting on June 19, 2019. Restricted Stock Unit awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan. The award vests on June 19, 2020. F2 · derivative.expiration_date: Restricted Stock Unit was granted on June 19, 2019, subject to shareholder approval of the Company's 2019 Equity Incentive Plan, which was obtained at the Company's annual shareholder meeting on June 19, 2019. Restricted Stock Unit awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan. The award vests on June 19, 2020. Read SEC document |
| June 19, 2019 Filed Jun 21, 2019 21:33 UTC | AGENUS INC AGEN · Entity 5774 | GrantStock Option, Right to buy · Derivative | 50,000 | $0.00 Strike: $2.38 | $0.00 |
DisclosureSEC source: 0000899243-19-017841 · doc4.xml · derivative · entry 1 Jeynes-Ellis Allison M · CIK 0001758521 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2029-01-01 F1 · derivative.exercise_date: Option was granted on January 1, 2019, subject to shareholder approval of the Company's 2019 Equity Incentive Plan, which was obtained at the Company's annual shareholder meeting on June 19, 2019. Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Incentive Plan. The option vests on January 1, 2020. Read SEC document |
| November 07, 2018 Filed Nov 14, 2018 19:50 UTC | AGENUS INC AGEN · Entity 5774 | GrantStock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $2.07 | $0.00 |
DisclosureSEC source: 0000899243-18-028886 · doc4.xml · derivative · entry 2 Jeynes-Ellis Allison M · CIK 0001758521 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2027-11-07 F2 · derivative.exercise_date: Represents the grant of an option to purchase shares of common stock. The stock option vests in three equal annual installments on each of November 7, 2019, 2020 and 2021. Read SEC document |
| November 07, 2018 Filed Nov 14, 2018 19:50 UTC | AGENUS INC AGEN · Entity 5774 | GrantCommon Stock | 28,985 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-18-028886 · doc4.xml · nonDerivative · entry 1 Jeynes-Ellis Allison M · CIK 0001758521 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,985 F1 · price: The securities described are restricted stock units and will vest on November 7, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.